ClinicalTrials.gov
public full text
Public Domain
A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment
This is a study where AZD5213 or placebo is given to patients with Mild Alzheimer's Disease or Mild Cognitive Impairment in a blinded and random assignment. The main study objective is to estimate the relationship of sleep duration versus dose after 4 weeks of treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate#829284
- Memory Training in Insomnia With Cognitive Impairment#805846
- An Open-label Study of AZD0120 in Adults With Multiple Sclerosis#1010438
- Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's Disease#836701
- Cognitive Behavioural Therapy for Insomnia on Sleep in Rheumatoid Arthritis.#828432
Record · ID 813135
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive